|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 11.10 USD | -2.29% |
|
-50.40% | +13.73% |
| 09-03 | Guggenheim Downgrades Alumis to Neutral From Buy | MT |
| 09-02 | Top Midday Gainers | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALUMIS INC. | Bio Therapeutic Drugs | -2.29% | -50.40% | +13.73% | +146.12% | - | 1.44B |  | |  |
- Stock Market
- Stocks
- ALMS Stock
- Charts Alumis Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
